Ingredient · Evidence grade C
S-equol for menopause: evidence, studies and safety
Last updated · 3 studies summarized
C Short answer: S-equol is a soy-derived compound (the active in Equelle) studied for occasional hot flashes and muscle aches associated with menopause*. Results are mixed, and the key trials were sponsored by companies behind the ingredient or product.
Key facts
| Evidence grade | C C |
|---|---|
| Use studied | hot flashes, muscle/joint aches |
| Trials | ~5–6 RCTs (Daily 2019 MA: 6 studies, 779 women) |
| Participants | 779 |
| What reviews conclude | Daily 2019 MA: benefit on hot-flash scores, 3/5 trials positive, 2 null; most trials <50/group. |
| The Menopause Society (2023) | Not recommended (Level II) – mixed evidence. |
| Also known as | Equelle, SE5-OH, EQ |
Grades: A strong · B moderate · C limited · D none or negative. How we grade.
Every study we reviewed
Each summary gives who took part, the dose, how long, the result compared with placebo or control, and who paid for it.
-
Equol Decreases Hot Flashes in Postmenopausal Women: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
An analysis of 6 trials found S-equol lowered hot-flash scores overall, but 2 of the 5 pooled trials found no benefit and most trials were small.
- Who
- 6 RCTs, 779 women
- Dose
- S-equol or isoflavones in equol producers
- Duration
- various
- Result
- Pooled benefit on hot-flash scores; 3 of 5 trials positive, 2 null.
- Funding
- Academic (Korea); not stated as industry funded. Independent / academic
-
A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women.
160 Japanese women who could not make equol themselves took 10 mg S-equol or placebo for 12 weeks. Hot flashes fell about 59% vs 35% on placebo. The ingredient's maker ran the research, and Japanese women tend to have milder hot flashes than US women.
- Who
- 160 Japanese equol non-producers (126 completed)
- Dose
- natural S-equol 10 mg/day
- Duration
- 12 weeks
- Result
- Hot flushes -58.7% vs -34.5% placebo (P=.009); less neck/shoulder stiffness.
- Funding
- Otsuka Pharmaceutical (developer of the S-equol ingredient used in Equelle). Industry-linked
-
A pilot study on the effects of S-equol compared to soy isoflavones on menopausal hot flash frequency.
The only US hot-flash trial of S-equol compared different doses with soy isoflavones, with no placebo group. All groups improved similarly; higher doses did slightly better. It was run by Pharmavite, which makes Equelle.
- Who
- 102 US postmenopausal women
- Dose
- S-equol 10, 20 or 40 mg/day vs soy isoflavones (no placebo)
- Duration
- 8 weeks
- Result
- Similar hot-flash reductions at week 8; 40 mg beat isoflavones on cumulative analysis; 10–20 mg better for muscle/joint pain.
- Funding
- Pharmavite LLC (Equelle maker) – lead author employee. Industry-linked
Safety
Soy-derived; avoid with soy allergy. Breast-cancer-history safety not established for concentrated isoflavone products. US trial lacked placebo; most data in Japanese women.
Ranked products that contain it
| Product | Amount per day | Score | $/day |
|---|---|---|---|
| Equelle Menopause Multi-Symptom Relief | S-equol: 10 mg | 47.4 | $1.40 |
FAQ
Does S-equol help with menopause symptoms?
S-equol is a soy-derived compound (the active in Equelle) studied for occasional hot flashes and muscle aches associated with menopause*. Results are mixed, and the key trials were sponsored by companies behind the ingredient or product. Our evidence grade is C. Daily 2019 MA: benefit on hot-flash scores, 3/5 trials positive, 2 null; most trials <50/group.
Does The Menopause Society recommend S-equol?
Not recommended (Level II) – mixed evidence. The 2023 nonhormone statement recommends no dietary supplement for hot flashes; talk to a clinician about hormone therapy and prescription options.
Is S-equol safe?
Soy-derived; avoid with soy allergy. Breast-cancer-history safety not established for concentrated isoflavone products. US trial lacked placebo; most data in Japanese women. Supplements are not FDA-approved before sale; ask a clinician or pharmacist, especially if you take medication.
Sources
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Solynes does not sell supplements; descriptions summarize published research and are not medical advice.